INIS
lymphomas
100%
therapy
42%
nanoparticles
28%
gold
28%
refractories
28%
patients
28%
engineering
14%
engineers
14%
optimization
14%
risks
14%
screens
14%
in vitro
14%
tumors
14%
delivery
14%
Medicine and Dentistry
Lymphoma
57%
Diffuse Large B-Cell Lymphoma
42%
Overall Survival
28%
Patient
28%
Combination Therapy
28%
Nanoshell
14%
In Vitro
14%
Survival Rate
14%
B-Cell Lymphoma
14%
Nanoparticle
14%
Deoxyribonucleotide
14%
Gold Nanoparticle
14%
Neoplasm
14%
Chemoimmunotherapy
14%
Photothermal Therapy
14%
Obstetric Delivery
14%
Therapeutic Procedure
14%
Pharmacology, Toxicology and Pharmaceutical Science
Lymphoma
57%
Diffuse Large B Cell Lymphoma
42%
Overall Survival
28%
Nanoparticle
14%
Gold Nanoparticle
14%
Deoxyribonucleotide
14%
Nanoshell
14%
Survival Rate
14%
Neoplasm
14%
B Cell Lymphoma
14%